Objectives: Widespread sensory deficits resembling hemihypoesthesia occur in 20% to 40% of chronic pain patients on the side of pain, independent of pain etiology, and have been termed nondermatomal sensory deficits (NDSDs). Sensory profiles have rarely been investigated in NDSDs.
D
iagnostic workup of patients with chronic pain is important for pain classification and appropriate treatment. In patients with chronic pain and sensory abnormalities, neuropathic pain may be suspected, and diagnostic workup according to current diagnostic criteria is recommended. 1 Some of those patients will not meet the diagnostic criteria for neuropathic pain, the cause of sensory disturbances remaining unclear. It is known that 25% to 50% of patients with chronic pain show widespread sensory deficits often resembling hemihypoesthesia on the side of pain or worse pain. 2, 3 This phenomenon is termed nondermatomal somatosensory deficits (NDSDs). 2, 3 NDSDs have been reported in various chronic nonneuropathic pain conditions, including myofascial pain, 2 and in complex regional pain syndrome (CRPS). 4 The first description of this phenomenon dates back to the 1920s. 5 It was considered to be "hysterical" or a sensory conversion disorder. Currently, NDSDs are recognized as a neuropsycho-biological condition 3, 6 but cannot be fully explained by a psychiatric disorder. 6, 7 Although no lesion of the central or peripheral nervous system has been identified, some functional abnormalities have been described in the literature. Functional magnetic resonance imaging (fMRI) studies showed altered patterns of activation in response to sensory stimuli in the somatosensory cortex and thalamus. 8 Recent neuroimaging studies also identified metabolic and structural changes in sensorimotor and temporal regions in patients with NDSD. 7, 9 The occurrence of NDSD in the absence of neurological cause has been suggested but not investigated systematically.
Quantitative sensory testing (QST) has been developed to provide sensory profiles in reference regions [10] [11] [12] and is widely used in research on chronic pain. 13 Sensory changes in painful regions and even beyond have been demonstrated in experimental pain such as in models of referred pain, 14 heat-induced pain, 15 or capsaicin-induced pain, 16 with a positive association between pain and sensory abnormalities-that is, increased pain was associated with an increase in sensory changes. 17 In various chronic pain conditions sensory changes were demonstrated by QST, including the area of referred pain, 18 bilateral regions in osteoarthritis, 19 widespread regions in fibromyalgia, 20, 21 areas within the affected segment in chronic back pain, 21 outside of the pain area in chronic low back pain, 22 myofascial temporomandibular joint disorder, 23, 24 and chronic back pain. [25] [26] [27] However, hemihypoesthesia in chronic pain verified using QST has been reported only in CRPS. 4 A comprehensive systematical neurological workup in patients with NDSD and chronic pain, including neurophysiology studies and sensory profiling with QST, is lacking.
Therefore, the objectives of the study were as follows: (1) to describe prospectively clinical, neurophysiological, and pain-related aspects in patients with chronic nonneuropathic pain with and without NDSD; (2) to investigate whether the clinical findings of NDSD can be confirmed by QST; and (3) to compare QST profiles of chronic non-neuropathic pain patients with and without NDSD. Potential pathophysiological mechanisms will be discussed.
MATERIALS AND METHODS

Patient Recruitment
The study cohort was the same as in a previous study 7 and has been described in brief. Local ethics committee approvals were obtained. Patients were recruited from the Centre for Pain Medicine, Nottwil, the Headache & Pain Unit, University Hospital Zurich, and the Psychosomatic Division, University Hospital Berne. All patients were evaluated in a multidisciplinary setting involving psychiatrists, psychologists, neurologists, rheumatologists, and orthopedists. Eligible patients were included after obtaining their informed consent. Inclusion criteria were the following: age between 20 and 65 years, sufficient understanding of the German language, pain duration for more than 6 months, normal neurological examination except for the presence of a reproducible unilateral sensory deficit in the NDSD group (including upper and lower extremities and trunk with possible involvement of the face), normal sensation in the pain-only group, normal neurophysiology results (nerve conduction studies [NCS] and somatosensory evoked potentials [SEP] of tibial nerves), and normal MRI of the brain. Exclusion criteria were the following: any neurological disease other than pain, inflammatory rheumatologic disorder, and severe psychiatric disorders requiring psychiatric hospitalization or associated with suicidality at any time. The inclusion procedure and all study-related investigations were performed at the Centre for Pain Medicine, Nottwil. For a rough estimate of the prevalence of NDSD in 1 study center (Nottwil) a database research was performed retrospectively, searching for patients with chronic pain and sensory deficits.
Pain Evaluation and Psychological Comorbidity
A standardized pain history was obtained using the validated pain questionnaire of the German Society for the Study of Pain, 28 including pain drawings. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS 29 ). Health-related quality of life was determined by the SF-12 questionnaire. 30 Chronic pain severity was assessed using the Graded Chronic Pain Scale. 31 The grade of pain chronification was defined by the Mainz Pain Staging System. 32 This is a questionnaire consisting of 11 items (pain characteristics, types of medication used, previous consultations of physicians, pain-related interventions and hospital admissions, and participation in rehabilitation programs) to assign the pain into 1 of 3 possible stages of disease chronification, which has been validated in several studies. 33, 34 From the pain drawings the number of affected body areas by pain (n of 53) were counted according to the areas (right, midline, and left body) described elsewhere. 35 
Clinical Examination
In all patients a comprehensive neurological examination was performed, focusing on the sensory system (esthesia, thermesthesia, and algesia), by 2 experienced neurologists (G.L. and F.R.) independently at different time points.
Esthesia was assessed with a standardized brush with a force of about 200 to 400 mN (Brush 05, Senselab, Sweden), thermesthesia with a cold roller (stainless steel, width 35 mm, diameter 25 mm, resting between investigations on a 100Â 40 Â5 mm stainless steel plate to keep the temperature constant at room air of about 221C), and algesia with a validated 40 g weighted pinprick (Neuropen, Owen Mumford, UK). The investigation of vibration sense was performed within the QST protocol (see below). We defined 80 body areas throughout the whole body, ventrally and dorsally, where all 3 qualities were tested. The report of diminished sensation after side-to-side comparison by the patient was drawn in body figures for each quality in separate drawings.
Neurophysiological Examination and Imaging
All patients underwent a neurophysiological examination in a quiet air-conditioned room with constant room temperature of 22.0 to 23.01C. NCS were performed for median and tibial nerves on the ipsilateral side (see below) and for sural nerves on both sides. Motor NCS (median and tibial nerves) included motor nerve conduction velocity, motor amplitudes, and F-wave studies. Sensory NCS (median and sural nerves) included sensory nerve conduction velocity and sensory amplitudes. In addition, SEP of tibial nerves on both sides were obtained, including latency P40 and amplitude P40/N45. A neurophysiology machine (VikingSelect, software VikingSelect Master Software version 11 by Nicolet, Biomedical) was used. Patients with any abnormalities indicating impaired peripheral of central neuronal conduction were excluded from the study. Procedures and normal values were used as described in the literature for NCS 36 and SEP. 37 
Thermography
Infrared thermography was performed under room conditions described above, after the patient had adapted to room conditions for 15 minutes, resting in a supine position. An infrared thermo camera (ThermaCam E4; Flir Systems) was used. Thermographs were taken perpendicular to the body surface with a camera body-distance of 100 cm for the face and 50 cm for the hands and feet.first, second, and third trigeminal nerve division. At the hand, reference points were set at the dorsum of the hand and dorsum of the distal phalanx of the first, third, and fifth finger (representing the dermatomes C6, C7, and C8); reference points were also set on the dorsum of the feet and dorsum of the distal phalanx of the first and fifth toe (representing the dermatomes L5 and S1). Temperature was recorded in 1C. According to the literature 38 a side-toside difference of at least 11C was considered abnormal.
QST
QST was performed according to the standardized protocol developed by the German Research Network on Neuropathic Pain (DFNS). 10 Room conditions were as described above. All tests were performed by the same medical technician (L.S.) who underwent a training program certified by DFNS. The tests were performed bilaterally in the face (cheek), dorsum of the hand, and dorsum of the foot. For thermal parameters, a standardized diagnostic device (TSA-II, Medoc, Israel, temperature range: 0 to 501C, baseline temperature 321C) with a 9.0 cm 2 contact surface of the thermode and related computer software (version 5.35) was used. Thermal tests were performed, including cold detection threshold (CDT), warm detection threshold (WDT), cold pain threshold (CPT), and heat pain threshold (HPT). The mechanical testing included the mechanical detection threshold (MDT), using a standardized set of modified von Frey hairs (Opti-hair2-Set, Marstock Nervtest, Germany), and the mechanical pain threshold (MPT) was tested using calibrated pinpricks (MRC Systems, Heidelberg, Germany). The vibration detection threshold (VDT) was examined using a RydelSeiffer tuning fork (64 Hz), which was applied over prominent bones, which is for the face the zygomatic process, for the hand the ulnar styloid process, and for the foot the medial malleolus. The pressure pain threshold (PPT) is measured over muscles. For the face, a pressure algometer (FDN100, Wagner Instruments, Greenwich) was applied over the masseter muscle. For the hand and foot, a pressure algometer (FDN200, Wagner Instruments) was applied over thenar eminence and abductor hallucis muscles, respectively.
Statistics
Clinical data were analyzed with IBM SPSS Statistics (version 20, IBM Corp., Armonk, NY). Independentsample t tests were used to compare normally distributed data, and the Mann-Whitney U test was utilized for nonnormally distributed continuous and ordinal data. w 2 or Fisher exact tests were used to compare categorical data between groups. In accordance with the DFNS protocol, 10 all QST values except CPT, HPT, and VDT were log transformed to achieve normal distribution. QST parameters were z-transformed before analysis, on the basis of agespecific and sex-specific reference data for each test site from the literature, according to the formula: Z-score = (X single patient -Mean controls )/SD controls ). 10 In the NDSD group "ipsilateral" was the side of pain or worse pain, which was in accordance with the side of sensory deficits of the clinical examination, except in 1 patient in whom sensory deficits were found at the opposite site to the worse pain site. In this patient the side of sensory deficit was chosen as ipsilateral. In the pain-only group "ipsilateral" was assigned to the side of pain, worse pain, or based on randomization if there was no pronounced pain side. A repeated measures analysis of variance with the between-subjects factor "group" (NDSD group and pain-only group) and the within-subjects factor "side" (ipsilateral-contralateral) was performed. As post hoc tests, independent-sample t tests were performed to compare parameters between the NDSD and pain-only groups on ipsilateral and contralateral sides, respectively, considering all Pr0.003 as statistically significant (after Bonferroni correction). In addition, side-to-side comparisons were performed using paired t tests in each patient group. The Bonferroni-Holm procedure was used to correct for multiple comparisons, analyzing 8 QST parameters. 39 Finally, possible relations between ipsilateral sensory loss and pain intensity as well as anxiety were investigated using the Spearman correlations. These analyses included patients with NDSD and "pain-only." The BonferroniHolm procedure was used to correct for multiple comparisons, as described above.
RESULTS
Patient Selection, Sociodemographic Data, Painrelated Data, and Psychological Comorbidity
For details of the selection procedure we refer to Supplemental Digital Content 1, Figure ( http://links. lww.com/CJP/A383). Seventy-five patients were contacted for the NDSD group and 77 patients for the "pain-only" group based on electronic chart records. Finally, 25 patients could be included in the NDSD group and 23 patients in the pain-only group. The Nottwil databank request revealed 107 patients with hemisensory deficits among 2995 unselected consecutive patients (including neuropathic pain, chronic non-neuropathic pain, or chronic nonneuropathic pain with neurological comorbidity) during a 4-year time period (2007 to 2010), which equals a prevalence of 3.6%.
Sociodemographic data, pain-related data, and psychological variables are shown in Table 1 . A full description of the psychological evaluation has been published elsewhere. 7 Age and sex were not significantly different between groups. The NDSD group showed a significantly more frequent migration background, predominantly from southeastern Europe, higher pain chronicity, higher grades of pain severity, lower physical health-related quality of life, and higher anxiety scores. The main pain diagnoses based on comprehensive multidisciplinary assessment were the following (NDSD/pain-only): headache (6/0), neck and upper-extremity pain of different etiologies (nonspecific 6/6, myofascial 3/0, facetogenic 0/4), back and lower-extremity pain of different etiologies (nonspecific 4/4, myofascial 2/3, facetogenic 0/5), nonspecific abdominal pain (1/0), fibromyalgia (1/1), and nonspecific hemibody pain (2/0). In addition to the main pain diagnosis, most patients had multiple additional pain locations. More detailed main pain diagnoses, distributions of all pain areas, and NDSD localizations are shown in Supplemental Digital Content 2, Table, (http://links.lww.com/CJP/A384) for the NDSD group. For the pain-only group detailed data related to pain diagnoses and pain location are shown in Supplemental Digital Content 3, Table ( http://links.lww.com/CJP/ A385). In the NDSD group significantly more body areas were affected by pain in comparison with the pain-only group (37.3% ± 15.4% vs. 24% ± 18.5%, P = 0.010). An exception of this observation was 1 patient with headache only (N37 with trigemino-autonomic headache) who had pronounced hemisensory deficits for all qualities.
Clinical Findings of Somatosensory Disturbances
The neurological examination was unremarkable except for hemibody sensory changes in the NDSD group, which were found on the right side in 15 patients and on the left side in 10 patients. In the NDSD group 2 patients had a full hemibody sensory deficit for all modalities at the side of worse pain (patient N11 and N27), 22 had incomplete hemisensory deficits for all qualities at the side of worse pain, whereas 1 patient had an incomplete diminished hemibody sensation for all qualities at the less affected pain side (patient N35). Eleven patients had diminished sensation in a hemibody distribution only on the side of pain or worse pain, whereas 11 patients had additional few areas of diminished sensation on the contralateral side. The percentage of affected areas with hypoesthesia correlated positively with the percentage of regions with thermhypoesthesia (Spearman r = 0.76; P < 0.001) and pinprick hypoalgesia (Spearman r = 0.76; P < 0.001). In 8 patients of the NDSD group the amount of body areas affected by NDSD was clearly more extensive than the amount of body areas affected by pain (patient N03, N13, N21, N24, N27, N30, N35, N37) (Supplemental Digital Content 2, Table, http://links.lww.com/CJP/A384).
Neurophysiology and Thermography
Neurophysiology and thermography studies in both groups were within normal limits and without significant side-to-side differences.
QST
Group and Side Differences
Increases in sensory threshold are related to loss of sensory function, and are shown with negative z-scores in Figure 1 . CDT was significantly higher in the NDSD group compared with the pain-only group in all 3 regions investigated ( Table 2 ). The significant interaction of "group" Â"side" for the facial region is consistent with higher ipsilateral (as compared with contralateral) CDT only in the NDSD group. This was confirmed by direct side-to-side comparisons. Post hoc tests showed that patients in the NDSD group had increased CDT compared with those in the pain-only group on the ipsilateral and contralateral sides in the facial region-that is, patients with NDSD had bilateral sensory loss in the face (Fig. 1) . WDT was significantly higher in the NDSD group compared with the pain-only group in the facial region but not in the hand and foot regions (confirmed by side-to-side comparisons). Post hoc tests revealed bilaterally increased WDT in the NDSD group compared with the pain-only group in the face. Side-to-side comparisons revealed increased ipsilateral WDT compared with contralateral WDT in the face only in NDSD patients. For CPT and HPT a significant interaction of "group" Â"side" in the foot region was found, indicating a significant increase in ipsilateral CPT compared with contralateral CPT and HPT only in the NDSD group (confirmed by side-to-side comparisons). MDT was significantly higher in the NDSD group compared with the pain-only group in all 3 regions investigated. The significant interaction of "group" Â "side" for all 3 regions is consistent with higher ipsilateral (as compared with contralateral) MDT in all regions only in the NDSD group (confirmed by side-to-side comparisons). MPT was significantly increased in the NDSD group in the hand and foot only on ipsilateral sides according to post hoc tests. Side-to-side comparisons detected increased MPT on the ipsilateral side compared with the contralateral side in the face and feet only in the NDSD group. VDT was significantly increased in the NDSD group in all 3 regions investigated. Post hoc tests revealed bilateral VDT increases in the NDSD group compared with the pain-only group for all 3 regions investigated. PPT was significantly decreased in the hand and foot regions in the NDSD group. Post hoc tests showed decreased PPT in the NDSD group compared with the pain-only group in the foot region on the contralateral side, whereas direct side-to-side differences showed no significant differences.
Summary of Side-to-Side Differences
Sensory profiles using z-transformation of both groups are summarized in Figure 1 . Sensory thresholds in original values before z-transformation are given in Supplemental Digital Content 4, for the NDSD group and in Supplemental Digital Content 5, Table, (http://links.lww.com/CJP/A387) for the painonly group. Patients in the NDSD group showed a significant increase for several thresholds on the side ipsilateral to pain: MDT was significantly increased in all 3 regions (face, P = 0.003; hand P = 0.001; foot P = 0.001). MPT was significantly increased in 2 regions (face, P = 0.005; foot, P = 0.035). Increases in 1 region were found for HPT (P = 0.002) and CPT (P = 0.002) in the foot, and for CDT (P = 0.007) and WDT (P = 0.009) in the face. Side differences were more pronounced in the face and foot regions compared with the hands. Patients in the pain-only group did not show significant side-to-side differences for any parameters investigated. . Increases in sensory threshold are related to loss of sensory function and are shown with negative z-scores ± SD. *Significant after correction for multiple comparisons. Significant post hoc comparisons between the NDSD group and the pain-only group are indicated with y. yP < 0.05 after correction for multiple comparisons: ipsilateral side of the NDSD group compared with ipsilateral side of the pain-only group. yyP < 0.05, after correction for multiple comparisons: differences between NDSD group and pain-only group on both ipsilateral and contralateral sides. The gray bar indicates the normal range based on literature data from healthy controls. 10 CDT indicates cold detection threshold; CPT, cold pain threshold; HPT, heat pain threshold; MDT, mechanical detection threshold; MPT, mechanical pain threshold; PPT, pressure pain threshold; QST, Quantitative sensory testing; VDT, vibration detection threshold; WDT, warm detection threshold. Contralateral and ipsilateral is referred to the side of pronounced pain in the NDSD group and in the painonly group to the randomized side.
Correlation of Sensory Thresholds on Ipsilateral Sides With Pain Intensity and Anxiety
Pain intensity was associated with loss of sensory function (negative z-scores) as opposed to a gain of function for pressure pain (positive z-scores), as summarized in Figure 2 . Pain intensity correlated negatively with zscores for VDT (face, hand), CDT (face), and MDT (hand) and positively with z-scores for PPT (face, hand). Anxiety was associated with losses of sensory function. Anxiety (HADS-A score) correlated negatively with z-scores for CDT (face), WDT (face), and VDT (face, hand, foot) (Fig. 3) .
DISCUSSION
The main findings of the present study were the following: (1) The phenomenon of NDSD in chronic pain is associated with a high burden of disease and more widespread pain. (2) Changes in sensory function in patients with NDSD can be objectified by QST: in the NDSD group significantly higher thresholds for mechanical and painful stimuli were found ipsilaterally to pain. Sensory loss correlated with pain intensity in several regions. Importantly, all patients had normal neurophysiology studies. 
Demography, Pain Characteristics, and Comorbidity
The NDSD cohort was comparable to that of previous studies with respect to demographic data. 2, 6, 9 Our findings of more frequent migration background, higher pain chronicity, higher grades of pain severity, lower physical health-related quality of life, and, as previously published, higher pain intensity, higher anxiety scores, and prevalence of absenteeism from work 7 in the NDSD group in comparison with the pain-only group indicate a higher burden of pain disease. Consistent with these findings, higher pain intensities and disease-related impairment in patients with NDSD have been reported in various studies. 2, 3, 6, 40 In our NDSD group, a relatively large proportion had migrated from Southeast Europe. It could be speculated that they might have experienced particularly stressful life events in war-torn countries, as NDSD has been related to traumatic life events previously. 6 In our patients with NDSD, a traumatic life event or a diagnosis of PTSD seemed slightly overrepresented, but this was not significant. 7 The estimated NDSD prevalence of 3.6% at 1 study center (Nottwil) was very low compared with previous studies that found a prevalence between 17% and 38% 2,41,42 in certain chronic pain cohorts. This may be related to sample characteristics such as a wide variety of different chronic pain diagnoses treated at the Nottwil center. As the inclusion criterion for the study was a hemisensory deficit, a wide variety of chronic non-neuropathic pain syndromes was included. Accordingly, NDSDs have been reported in several chronic non-neuropathic pain conditions, 2-4,41-43 but extension of painful regions has not been described. Therefore, our finding of more extensive pain sites in the NDSD group suggests that NDSDs are observed particularly in widespread pain syndromes. As an exception of this observation we found NDSD in 1 patient who had onesided headache as the only pain location.
Neurophysiology, Thermography, and Neuroimaging
The present cohort was investigated with prospective neurophysiology studies and brain imaging 7 to rule out gross functional abnormalities and structural pathology. Normal neurophysiology and imaging of the nervous system have been reported in chronic pain patients with NDSD based on chart reviews but have not been systematically studied in previous studies. 2, 6, 9 In contrast, in CRPS with NDSD, several abnormalities in NCS, SEP, and sympathetic skin response were found, suggesting different underlying or concomitant pathology in the case of CRPS. 4 In the literature, NDSDs have occasionally been described in radiculopathy with SEP and MRI abnormalities. 44 Our study demonstrates that NDSD can be observed in patients with chronic non-neuropathic pain syndromes in the absence of neurophysiological abnormalities. Normal infrared thermography in our groups suggests lack of involvement of the vasomotor system. In contrast, the appearance of NDSD in the context of an injury of the sympathetic nervous system has been suggested in the past. 45 
Clinical Somatosensory Findings and QST
In our cohort, diminished sensation in a hemibody distribution on the side of pain or worse pain was present in nearly all patients with NDSD, although 1 patient with frequent migraine had NDSD at the less pronounced pain side. In addition, about half of the patients with NDSD had additional spots of diminished sensation opposite to the pain side. In rare cases, NDSDs have been described as occurring on the side opposite to pain. 3 In the clinical examination, we found abnormalities for esthesia, algesia, and thermesthesia to be associated with each other, suggesting that these abnormalities are frequently observed together and should be examined in daily practice. This observation was reflected in QST where loss of function was found for MDT in 3, for MPT in 2, and for CDT, WDT, CPT, and HPT in 1 test region ipsilateral to pain. Thus, significant side-to-side differences were not found for all parameters in every region. This may be explained by the following reasons: (1) incomplete expression of NDSD in some patients, (2) wide variations in the extent of pain distribution at the most affected side and at the opposite side, (3) minor negative signs at the opposite side in the clinical examination in some patients and bilateral sensory changes in QST as outlined below, and (4) the extensive QST protocol being performed only in reference regions. . Correlations between pain intensity and sensory thresholds on ipsilateral sides for CDT, WDT, MDT, VDT, and PPT. *Significant after correction for multiple comparisons. In the scatterplot the x-axis corresponds to the z-transformed sensory threshold, and the y-axis to pain intensity (von Korff). Pain intensity is associated with a loss of function for several parameters and a gain of function for pressure pain (PPT). CDT indicates cold detection threshold; MDT, mechanical detection threshold; VDT, vibration detection threshold; WDT, warm detection threshold.
Widespread sensory abnormalities in NDSD involve small fiber and thick myelinated fiber function in the periphery, as well as spinothalamic and dorsal column pathways centrally at the spinal cord level. This suggests the involvement of supraspinal rather than spinal mechanisms within the CNS, which is consistent with neuroimaging studies discussed below. As sensory aspects of pain and sensory perception are mediated by the lateral pain system, including the thalamus, insular cortex, and somatosensory cortex, 46 chronic pain input from the same body side may interfere with sensory processing and modulate, respectively, suppress sensory perception. Previously, it has been hypothesized that NDSDs may result from an attempt of the brain to shut down all input from painful regions, which is insufficient for adequate pain control but causes sensory loss for various sensory abnormalities. 8 Consistent with this idea, sensory loss correlated with pain intensity in several regions in the present study. Reduced perception for sensory or painful stimuli was associated with deactivation or lack of activation in the contralateral primary and secondary somatosensory cortex and a lack of activation in the contralateral thalamus 8, 47 in fMRI studies.
Functional and structural neuroimaging studies 7-9 also showed bilateral alterations in NDSD, which could relate to the bilateral sensory abnormalities for vibration and temperature sensation found in the present study. A positron emission tomography study in NDSD patients showed a significant hypometabolic pattern of changes in the cortical and subcortical areas bilaterally 9 involving limbic regions. Dysfunctional sensory processing in patients with NDSD is associated with complex bilateral changes in gray matter volume, including the somatosensory system and temporal regions involved in multisensory integration. 7 The gain of function for pressure pain, which correlated with pain intensity, increased sensitivity to gentle palpation in the area of sensory deficits, 3 and the observation of more widespread pain in NDSD can be interpreted as a sign of central sensitization. In this condition an increased responsiveness of neurons to their normal input occurs because of a drop in sensory thresholds probably involving a dysfunction of the endogenous pain control systems at the brainstem level. 48, 49 It could be assumed that the spreading of pain is a clinical manifestation of central sensitization that has occurred in chronic pain patients under stressful conditions, as seen in various chronic pain syndromes. 50 We hypothesize that NDSDs may also result from maladaptive central mechanisms trying to counteract central sensitization that has already occurred in a chronic pain population, which are, however, insufficient to control pain but cause widespread hypoesthesia for several sensory modalities. This may involve descending inhibitory mechanisms at the level of the brainstem.
Intriguingly, bilateral localized sensory loss has been reported in experimental pain models 14 and in localized chronic pain. 18, 19, 22 In addition, increased local sensitivity to pressure pain has been consistently reported in chronic non-neuropathic pain patients 18, 51, 52 in combination with additional negative signs.
The correlation of anxiety with sensory loss for thermal and vibration sense may be an example of how psychosocial stress may interact with sensory processing in chronic pain. This may be mediated by the medial pain system in which motivational-affective factors interact with pain perception. 49 Afferent projections to this area have been demonstrated. 53 Considering studies on fibromyalgia, reporting evidence of small fiber neuropathy based on QST findings and skin biopsy, it could be discussed whether the observed sensory changes may be related to small fiber neuropathy, which cannot be ruled out by normal NCS. 54 However, sensory profiles with unilateral and bilateral alterations, also involving gain of function for pressure pain, with pronounced changes in the face are not suggestive for localized distal small fiber neuropathy. Rather, involvement of different sensory modalities points toward central dysfunction.
To our knowledge QST has not been studied systematically in patients with chronic non-neuropathic pain with NDSD. QST data have been reported in patients with CRPS I and II and NDSD 4 showing significantly increased thresholds to touch, warm and cold sensation, as well as for heat pain in 5 tested regions at the side of CRPS.
Limitations of the Study
Although QST has been validated in several clinical trials and has been shown to provide reproducible results, 55 it remains a psychophysical method, dependent on the patient's attention and compliance.
QST as a time-consuming method could only be applied in selected body areas such as the face, hand and foot bilaterally in this study. Effort was made to demonstrate extensive sensory changes beyond the pain area. In the present study, QST was not performed within the area of maximum pain. Therefore, our results were not comparable to those of most studies investigating sensory pain profiling within the pain maximum. Finally, vibration sense was not included in the extensive screening procedure based on esthesia, thermesthesia, and algesia. Thus, it cannot be fully excluded that bilateral loss in VDT was observed because unilateral loss in vibration sense was not an inclusion criterion. However, bilateral changes were also found for modalities included in the screening procedure, such as CDT and WDT.
CLINICAL PERSPECTIVE AND CONCLUSIONS
Pain phenotyping recently became a major field in research to improve patients' response to treatment. 56 For psychological phenotyping the HADS and for sensory phenotyping the DFNS QST battery are recommended. 56 We showed a correlation of psychological phenotype markers such as anxiety and pain intensity with several QST parameters.
The association of affective disturbances and chronic pain is widely recognized. 57 Psychosocial phenotyping in our study revealed that the occurrence of NDSD in chronic pain patients is associated with more extensive pain sites, higher ratings for anxiety, lower physical quality of life, higher grades of pain severity and chronicity, and higher prevalence of migration background. NDSD may be regarded as a pain phenotype expressing a higher burden of pain disease.
The combination of loss of function for thermal and mechanical modalities and gain of function for mechanical pressure pain as a sign of sensitization in NDSD may have an impact on the management of patients with chronic nonneuropathic pain. Further studies are indicated with a focus on QST in chronic non-neuropathic pain with or without NDSD to evaluate conceptions of pain phenotyping and treatment response.
